AVANOS MEDICAL, INC. Quarterly Depreciation in USD from Q3 2013 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Avanos Medical, Inc. quarterly/annual Depreciation history and growth rate from Q3 2013 to Q3 2024.
  • Avanos Medical, Inc. Depreciation for the quarter ending September 30, 2024 was $5.3M, a 10.4% increase year-over-year.
  • Avanos Medical, Inc. Depreciation for the twelve months ending September 30, 2024 was $20.6M, a 18.4% increase year-over-year.
  • Avanos Medical, Inc. annual Depreciation for 2023 was $19.2M, a 9.71% increase from 2022.
  • Avanos Medical, Inc. annual Depreciation for 2022 was $17.5M, a 2.94% increase from 2021.
  • Avanos Medical, Inc. annual Depreciation for 2021 was $17M, a 27.7% decline from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $20.6M $5.3M +$500K +10.4% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-30
Q2 2024 $20.1M $5M +$500K +11.1% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-31
Q1 2024 $19.6M $5.3M +$400K +8.16% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $19.2M $5M +$1.8M +56.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-21
Q3 2023 $17.4M $4.8M +$300K +6.67% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-30
Q2 2023 $17.1M $4.5M +$100K +2.27% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-31
Q1 2023 $17M $4.9M -$500K -9.26% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 $17.5M $3.2M +$2.5M +357% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-21
Q3 2022 $15M $4.5M -$900K -16.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
Q2 2022 $15.9M $4.4M -$1M -18.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $16.9M $5.4M -$100K -1.82% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 $17M $700K -$5.3M -88.3% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-21
Q3 2021 $22.3M $5.4M -$400K -6.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-02
Q2 2021 $22.7M $5.4M -$500K -8.48% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $23.2M $5.5M -$300K -5.17% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 $23.5M $6M -$100K -1.64% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-21
Q3 2020 $23.6M $5.8M +$2.3M +65.7% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 $21.3M $5.9M +$2.2M +59.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-03
Q1 2020 $19.1M $5.8M +$2.2M +61.1% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 $16.9M $6.1M +$2.5M +69.4% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-23
Q3 2019 $14.4M $3.5M $0 0% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-03
Q2 2019 $14.4M $3.7M +$500K +15.6% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-04
Q1 2019 $13.9M $3.6M +$400K +12.5% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 $13.5M $3.6M -$300K -7.69% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-19
Q3 2018 $13.8M $3.5M -$1.4M -28.6% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-05
Q2 2018 $15.2M $3.2M -$1.9M -37.3% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 $17.1M $3.2M -$1.7M -34.7% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 $18.8M $3.9M +$15.9M Oct 1, 2017 Dec 31, 2017 10-K 2020-02-25
Q3 2017 $2.9M $4.9M -$6.1M -55.5% Jul 1, 2017 Sep 30, 2017 10-Q/A 2018-12-17
Q2 2017 $9M $5.1M -$5.9M -53.6% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 $14.9M $4.9M -$5.1M -51% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-02
Q4 2016 $20M -$12M $0 0% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-26
Q3 2016 $20M $11M +$1M +10% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-01
Q2 2016 $19M $11M +$2M +22.2% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-02
Q1 2016 $17M $10M $0 0% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-02
Q4 2015 $17M -$12M -$27M -180% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-27
Q3 2015 $44M $10M -$9M -47.4% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-03
Q2 2015 $53M $9M -$1M -10% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-05
Q1 2015 $54M $10M +$1M +11.1% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 $53M $15M Oct 1, 2014 Dec 31, 2014 10-K 2017-02-27
Q3 2014 $19M +$9M +90% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-04
Q2 2014 $10M Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-12
Q1 2014 $9M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-05
Q3 2013 $10M Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.